Schnellsuche

Top 5 Aktien

Integral Metals Corp.

20.11.

0,60 €

+1400,00 %
CMC Metals Ltd.

20.11.

0,024 €

+555,56 %
Monarca Minerals Inc.

20.11.

0,004 €

+300,00 %
Route 109 Resources Inc.

20.11.

0,092 €

+145,33 %
Origen Resources Inc.

20.11.

0,049 €

+142,57 %

weitere

Kurzprofile von Minen

Flop 5 Aktien

Bravada Gold Corp.

20.11.

0,0035 €

-56,25 %
Advanced Gold Exploration Inc.

15.11.

0,007 €

-39,13 %
Torrent Gold Inc.

20.11.

0,01 €

-33,33 %
Hot Chili Ltd.

19.11.

0,442 €

-19,64 %

weitere

Minen Minen Peak Rare Earths Ltd.Nachrichten

Peak Rare Earths Ltd.

Branche:

Bergbau

Heimatland:

Australien

Hauptrohstoff:

Seltene Erden

Aktiengattung:

Originalaktie

WKN / ISIN:

A0LA5V / AU000000PEK2

Art:

Minengesellschaft

Rohstoffe:

AuAgPtPdCuNiZn, Seltene Erden

Projekte in:

Positive Drill Results at Ngualla Rare Earth Project

WEST PERTH, AUSTRALIA -- (Marketwire) -- 11/09/12 -- Peak Resources Limited ("Peak" or "the Company") (ASX: PEK) (OTCQX: PKRLY), the developer of a potentially low cost, long term rare earth project in Tanzania, today announced additional new drill results from its 100%-owned Ngualla Rare Earth Project in Tanzania.

The results extend the current [...]

weiterlesen

09.11.2012

von Marketwire
Peak Resources Announces Availability of Its Fiscal Q1 2013 Quarterly Report

Peak Resources Limited, the developer of a potentially low cost, long term rare earth project in Tanzania, today announced that its quarterly report for the three months ended September 30, 2012 is available on its corporate website. The following is a summary of key accomplishments during Q1 2013:

weiterlesen

30.10.2012

von Marketwire
Peak Resources Announces Availability of Its 2012 Annual Report

WEST PERTH, AUSTRALIA -- (Marketwire) -- 10/25/12 -- Peak Resources Limited ("Peak" or "the Company") (ASX: PEK) (OTCQX: PKRLY), the developer of a potentially low cost, long term rare earth project in Tanzania, today announced that its 2012 Annual Report is available for public viewing.

In the past year, Peak has advanced rapidly from [...]

weiterlesen

25.10.2012

von Marketwire
Peak Resources Announces Appointment of Chief Financial Officer/Company Secretary

WEST PERTH, AUSTRALIA -- (Marketwire) -- 10/15/12 -- Peak Resources Limited (Peak) (ASX: PEK) (OTCQX: PKRLY), the developer of a potentially low cost, long term rare earth project in Tanzania, today announced the appointment of Mr. Jeff Dawkins as its Chief Financial Officer. This appointment is effective as of 15 October 2012.

Mr. Dawkins will [...]

weiterlesen

15.10.2012

von Marketwire
Peak Resources to Complete Key Scoping Study for Ngualla Rare Earth Project in December

WEST PERTH, AUSTRALIA -- (Marketwire) -- 09/28/12 -- Peak Resources Limited (Peak) (ASX: PEK) (OTCQX: PKRLY) (PINKSHEETS: PKRLY), the developer of a potentially low cost, long term rare earth project in Tanzania, today provided an update on the Scoping Study ("the Study") at its 100%-owned Ngualla rare earth project ("the project"). The project [...]

weiterlesen

28.09.2012

von Marketwire
Peak Resources Maiden High Grade Rare Earth Product From Metallurgical Program

WEST PERTH, AUSTRALIA -- (Marketwire) -- 08/23/12 -- Peak Resources Limited (Peak) (ASX: PEK) (OTCQX: PKRLY) (PINKSHEETS: PKRLY), the developer of a potentially low cost, long term rare earth project in Tanzania, is pleased to announce it has successfully demonstrated a simple metallurgical flowsheet resulting in a high grade, high purity rare [...]

weiterlesen

23.08.2012

von Marketwire
Peak Resources Announces Wide High Grade Drill Results From Surface at Ngualla Rare Earth Project

WEST PERTH, AUSTRALIA -- (Marketwire) -- 08/01/12 -- Peak Resources Limited (Peak) (ASX: PEK) (OTCQX: PKRLY) (PINKSHEETS: PKRLY), the developer of a potentially low cost, long term rare earth project in Tanzania, is pleased to announce several new high grade rare earth mineralised intersections from surface at its 100%-owned Ngualla Rare Earth [...]

weiterlesen

01.08.2012

von Marketwire
Peak Resources Announces $5.5 Million Private Placement Placement Was Oversubscribed

Placement Was OversubscribedWEST PERTH, AUSTRALIA -- (Marketwire) -- 07/27/12 -- Peak Resources Limited ("Peak") (ASX: PEK) (OTCQX: PKRLY) (PINKSHEETS: PKRLY) today announced that the Company has received commitments from institutional and accredited investors to raise $5.5 million through a private placement ("Placement"). Proceeds from the [...]

weiterlesen

27.07.2012

von Marketwire
Peak Resources Announces Initial Results From 2012 Drilling Program at Ngualla

WEST PERTH, AUSTRALIA -- (Marketwire) -- 07/23/12 -- Peak Resources Limited ("Peak") (ASX: PEK) (OTCQX: PKRLY) (PINKSHEETS: PKRLY) today announced the first assay results from its 2012 drilling program at Ngualla in southern Tanzania.
Highlights:Intersections returned from the first six holes within the Southern Rare Earth Zone indicate several [...]

weiterlesen

23.07.2012

von Marketwire
Peak Resources Limited Provides Update on Ngualla Rare Earth Project

Peak is pleased to provide a progress report on the development of a mineral processing route for its 100% owned rare earth Ngualla Rare Earth Project. Ngualla is the world's fifth largest rare earth deposit outside of China and the highest grade of the top seven. Ngualla is potentially a low-cost, long term rare earth project located in Tanzania.

weiterlesen

11.07.2012

von Marketwire
Peak Resources Commences Trading on the OTCQX Under the Symbol “PKRLY“

Peak Resources, a company engaged in the exploration and evaluation of mineral licenses in Australia and Tanzania, is pleased to announce that its common shares are now trading on the highest tier of the OTC market, OTCQX. "We are extremely pleased to join the prestigious tier OTCQX," said Richard Beazley, Managing Director of Peak Resources. "The [...]

weiterlesen

28.06.2012

von Marketwire
Viralytics - Receive Chinese Notice To Grant Patent Of Use Of EVATAK(TM) In Ovarian Cancer

Viralytics received a patent granting notice from China regarding the use of EVATAK(TM) as an anti-cancer agent in human ovarian cancer. The Company also has a Phase II Investigational New Drug application for late stage melanoma patients under discussion with the US Food and Drug Administration using its lead oncolytic virus, CAVATAK(TM). Two [...]

weiterlesen

24.02.2011

von ABN Newswire

zurück <1 2 34